Cargando…
Personalized rosuvastatin therapy in problem patients with partial statin intolerance
INTRODUCTION: The aim was to study the pharmacogenetic determinants of switching simvastatin-intolerant ethnic Uzbek patients with coronary artery disease (CAD) to rosuvastatin treatment. MATERIAL AND METHODS: The study included 50 patients with CAD, who demonstrated statin-induced adverse liver sym...
Autores principales: | Shek, Aleksandr B., Kurbanov, Ravshanbek D., Alieva, Rano B., Abdullaeva, Guzal J., Nagay, Aleksandr V., Abdullaev, Alisher A., Hoshimov, Shavkat U., Nizamov, Ulugbek I. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Termedia Publishing House
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6374586/ https://www.ncbi.nlm.nih.gov/pubmed/30775595 http://dx.doi.org/10.5114/amsad.2018.76826 |
Ejemplares similares
-
Simvastatin intolerance genetic determinants: some features in ethnic Uzbek patients with coronary artery disease
por: Shek, Aleksandr B., et al.
Publicado: (2017) -
Can metformin stabilize PCSK9 level in stable coronary artery disease patients treated with statins?
por: Shek, Aleksandr B., et al.
Publicado: (2019) -
E670G PCSK9 polymorphism in HeFH & CAD with diabetes: is the bridge to personalized therapy within reach?
por: Alieva, Rano, et al.
Publicado: (2023) -
Management of statin intolerance
por: Raju, Soma B., et al.
Publicado: (2013) -
Statin Intolerance and Suboptimal Statin Therapy
por: Tada, Hayato, et al.
Publicado: (2019)